Professional Documents
Culture Documents
Who Di 32-4 Atc-Ddd PDF
Who Di 32-4 Atc-Ddd PDF
Who Di 32-4 Atc-Ddd PDF
4, 2018
ATC/DDD classification
The Anatomical Therapeutic Chemical (ATC) classification system and the
Defined Daily Dose (DDD) as a measuring unit are tools for exchanging and
comparing data on drug use at international, national or local levels. The ATC/
DDD system has become the gold standard for international drug utilization
research. It is maintained by the WHO Collaborating Centre for Drug Statistics
Methodology in Oslo, Norway. Visit www.whocc.no/ for more information.
Comments or objections to the decisions from the meeting should be forwarded to the
WHO Collaborating Centre for Drug Statistics Methodology before 1 February 2019. If no
objections are received before this date, the new ATC codes and DDDs will be considered
final and included in the January 2020 version of the ATC/DDD Index.
551
ATC/DDD classification WHO Drug Information Vol. 32, No. 4, 2018
552
WHO Drug Information Vol. 32, No. 4, 2018 ATC/DDD classification
1 Nasal formulations indicated for major depressive disorders. Parenteral formulations are classified in N01AX14
553
ATC/DDD classification WHO Drug Information Vol. 32, No. 4, 2018
New DDDs
ATC level name/INN DDD unit Adm.R* ATC code
amenamevir 0.4 g O J05AX26
apalutamide 0.24 g O L02BB05
asunaprevir 0.2 g O J05AP06
brodalumab 15 mg P L04AC12
calcium aminosalicylate 15 g O J04AA03
cerliponase alfa 21 mg P A16AB17
elbasvir 50 mg O J05AP10
enviomycin 1 g P J04AB06
erenumab 2.5 mg P N02CX07
favipiravir 1.6 g O J05AX27
glycerol phenylbutyrate 15 g O A16AX09
grazoprevir 0.1 g O J05AP11
laninamivir 40 mg Inhal.powder J05AH04
levofloxacin 0.24 g Inhal.solution J01MA12
nabilone 3 mg O A04AD11
Continued
554
WHO Drug Information Vol. 32, No. 4, 2018 ATC/DDD classification
Changes of DDDs
ATC level name/INN Previous DDD New DDD ATC code
555
ATC/DDD classification WHO Drug Information Vol. 32, No. 4, 2018
These are considered as final and will be included in the January 2019 version of the
ATC/DDD Index.
556
WHO Drug Information Vol. 32, No. 4, 2018 ATC/DDD classification
557
ATC/DDD classification WHO Drug Information Vol. 32, No. 4, 2018
New DDDs
ATC level name/INN DDD unit Adm.R* ATC code
artemether 0.28 g R P01BE02
artesunate 0.28 g R P01BE03
benralizumab 0.54 mg P R03DX10
chenodeoxycholic acid 1 g O A05AA01
cladribine 0.34 mg O L04AA40
dupilumab 21.4 mg P D11AH05
emicizumab 15 mg P B02BX06
ertugliflozin 10 mg O A10BK04
guselkumab 1.79 mg P L04AC16
letermovir 0.48 g O,P J05AX18
ocrelizumab 3.29 mg P L04AA36
patiromer calcium 8.4 g O V03AE09
rolapitant 0.18 g O A04AD14
telotristat 0.75 g O A16AX15
* Administration Route: O = oral; P= parenteral.
Change of DDD
ATC level name/INN Previous DDD New DDD ATC code
1
refers to fosaprepitant
***
558